ABBOTT LABORATORIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.9 USD | -0.35% |
|
-0.88% | -3.77% |
| 04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
| 04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 184B | ||||||
| 107B | ||||||
| 69.44B | ||||||
| 50.37B | ||||||
| 44.82B | ||||||
| 41.53B |
- Stock Market
- Equities
- ABT Stock
- Charts Abbott Laboratories
- Sector Chart
